410 related articles for article (PubMed ID: 15911761)
1. Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease.
Whitworth AJ; Theodore DA; Greene JC; Benes H; Wes PD; Pallanck LJ
Proc Natl Acad Sci U S A; 2005 May; 102(22):8024-9. PubMed ID: 15911761
[TBL] [Abstract][Full Text] [Related]
2. Glutathione S-transferase omega suppresses the defective phenotypes caused by PINK1 loss-of-function in Drosophila.
Kim K; Yim J
Biochem Biophys Res Commun; 2013 Aug; 437(4):615-9. PubMed ID: 23867819
[TBL] [Abstract][Full Text] [Related]
3. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin.
Clark IE; Dodson MW; Jiang C; Cao JH; Huh JR; Seol JH; Yoo SJ; Hay BA; Guo M
Nature; 2006 Jun; 441(7097):1162-6. PubMed ID: 16672981
[TBL] [Abstract][Full Text] [Related]
4. A Drosophila model of mutant human parkin-induced toxicity demonstrates selective loss of dopaminergic neurons and dependence on cellular dopamine.
Sang TK; Chang HY; Lawless GM; Ratnaparkhi A; Mee L; Ackerson LC; Maidment NT; Krantz DE; Jackson GR
J Neurosci; 2007 Jan; 27(5):981-92. PubMed ID: 17267552
[TBL] [Abstract][Full Text] [Related]
5. Drosophila PINK1 and parkin loss-of-function mutants display a range of non-motor Parkinson's disease phenotypes.
Julienne H; Buhl E; Leslie DS; Hodge JJL
Neurobiol Dis; 2017 Aug; 104():15-23. PubMed ID: 28435104
[TBL] [Abstract][Full Text] [Related]
6. Nicotine increases lifespan and rescues olfactory and motor deficits in a Drosophila model of Parkinson's disease.
Chambers RP; Call GB; Meyer D; Smith J; Techau JA; Pearman K; Buhlman LM
Behav Brain Res; 2013 Sep; 253():95-102. PubMed ID: 23871228
[TBL] [Abstract][Full Text] [Related]
7. Glutathione s-transferase omega 1 activity is sufficient to suppress neurodegeneration in a Drosophila model of Parkinson disease.
Kim K; Kim SH; Kim J; Kim H; Yim J
J Biol Chem; 2012 Feb; 287(9):6628-41. PubMed ID: 22219196
[TBL] [Abstract][Full Text] [Related]
8. Parkin counteracts symptoms in a Drosophila model of Parkinson's disease.
Haywood AF; Staveley BE
BMC Neurosci; 2004 Apr; 5():14. PubMed ID: 15090075
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation rescues anomalies associated with knockdown of parkin in dopaminergic and serotonergic neurons in Drosophila model of Parkinson's disease.
Srivastav S; Singh SK; Yadav AK; Srikrishna S
Biochem Biophys Res Commun; 2015 May; 460(3):780-5. PubMed ID: 25824034
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin.
Park J; Lee SB; Lee S; Kim Y; Song S; Kim S; Bae E; Kim J; Shong M; Kim JM; Chung J
Nature; 2006 Jun; 441(7097):1157-61. PubMed ID: 16672980
[TBL] [Abstract][Full Text] [Related]
11. Induction of the phase II detoxification pathway suppresses neuron loss in Drosophila models of Parkinson's disease.
Trinh K; Moore K; Wes PD; Muchowski PJ; Dey J; Andrews L; Pallanck LJ
J Neurosci; 2008 Jan; 28(2):465-72. PubMed ID: 18184789
[TBL] [Abstract][Full Text] [Related]
12. Analysis of dopaminergic neuronal dysfunction in genetic and toxin-induced models of Parkinson's disease in Drosophila.
Navarro JA; Heßner S; Yenisetti SC; Bayersdorfer F; Zhang L; Voigt A; Schneuwly S; Botella JA
J Neurochem; 2014 Nov; 131(3):369-82. PubMed ID: 25040725
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Buffy enhances the loss of parkin and suppresses the loss of Pink1 phenotypes in Drosophila.
M'Angale PG; Staveley BE
Genome; 2017 Mar; 60(3):241-247. PubMed ID: 28106473
[TBL] [Abstract][Full Text] [Related]
14. Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila.
Yang Y; Nishimura I; Imai Y; Takahashi R; Lu B
Neuron; 2003 Mar; 37(6):911-24. PubMed ID: 12670421
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin.
Yang Y; Gehrke S; Imai Y; Huang Z; Ouyang Y; Wang JW; Yang L; Beal MF; Vogel H; Lu B
Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10793-8. PubMed ID: 16818890
[TBL] [Abstract][Full Text] [Related]
16. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
17. Mutant alpha-synuclein-induced degeneration is reduced by parkin in a fly model of Parkinson's disease.
Haywood AF; Staveley BE
Genome; 2006 May; 49(5):505-10. PubMed ID: 16767175
[TBL] [Abstract][Full Text] [Related]
18. Extended lifespan of Drosophila parkin mutants through sequestration of redox-active metals and enhancement of anti-oxidative pathways.
Saini N; Oelhafen S; Hua H; Georgiev O; Schaffner W; Büeler H
Neurobiol Dis; 2010 Oct; 40(1):82-92. PubMed ID: 20483372
[TBL] [Abstract][Full Text] [Related]
19. Mask loss-of-function rescues mitochondrial impairment and muscle degeneration of Drosophila pink1 and parkin mutants.
Zhu M; Li X; Tian X; Wu C
Hum Mol Genet; 2015 Jun; 24(11):3272-85. PubMed ID: 25743185
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants.
Greene JC; Whitworth AJ; Kuo I; Andrews LA; Feany MB; Pallanck LJ
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4078-83. PubMed ID: 12642658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]